RHYTHM PHARMACEUTICALS ANNOUNCES COMMERCIAL LAUNCH OF IMCIVREE® (SETMELANOTIDE) IN JAPAN FOR PATIENTS WITH ACQUIRED HYPOTHALAMIC OBESITY

Reuters · 2d ago

Please log in to view news